Status: Recruiting
The Immune Assessment of PD-1 Antibody Therapy in Tumor
This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.
Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Quanli GaoUpdated: Nov 18, 2024Locations: 1
Eligibility criteria
Age ≥18 years. [+3]
Age <18 years. [+3]